Home > News > Nucryst Looks to Zap Zits
March 10th, 2006
Nucryst Looks to Zap Zits
Jack Uldrich: Yesterday, Nucryst announced that it had been granted a new patent that covers the company’s poprietary nanocrystalline silver for treating acne.
Given the number of teenagers that still suffer from this vexing condition, the patent could prove to be very profitable for the company. In my estimation, however, this news alone is not enough to change my bearish opinion of Nucryst.
FEI Company Announces Date for Investor Conference Participation March 3rd, 2014
Industrial Nanotech, Inc. Completes On Site Visit by PCAOB Audit Firm - Nears Completion of Audit in Preparation for Move to a Senior Stock Exchange in Late 2014 February 27th, 2014
Harris & Harris Group Announces the Consulting Engagement of Peter J. Boni as a Senior Advisor February 26th, 2014
Harris & Harris Group Notes Metabolon's Agreement With The Carlos Slim Institute, Patia And Clinica Ruiz For Quantose Prediabetes Test In Mexico February 25th, 2014